Aadi Historical Income Statement

AADI Stock

USD 1.80 0.02 1.10%

Historical analysis of Aadi Bioscience income statement accounts such as Total Operating Expenses of 98.2 M, Interest Expense of 224.8 K or Selling General Administrative of 47.6 M can show how well Aadi Bioscience performed in making a profits. Evaluating Aadi Bioscience income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Aadi Bioscience's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Aadi Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aadi Bioscience is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

About Aadi Income Statement Analysis

Aadi Bioscience Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Aadi Bioscience shareholders. The income statement also shows Aadi investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Aadi Bioscience Income Statement Chart

Aadi Bioscience Income Statement is one of the three primary financial statements used for reporting Aadi's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Aadi Bioscience revenue and expense. Aadi Bioscience Income Statement primarily focuses on the company's revenues and expenses during a particular period.

As of now, Aadi Bioscience's Gross Profit is increasing as compared to previous years. The Aadi Bioscience's current Cost Of Revenue is estimated to increase to about 2.9 M, while Operating Income is forecasted to increase to (68.3 M).

Other Operating Expenses Selling General Administrative Cost Of Revenue Research Development

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Aadi Bioscience. It is also known as Aadi Bioscience overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Aadi Bioscience income statement and represents the costs associated with goods and services Aadi Bioscience provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Aadi Bioscience's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Aadi Bioscience current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.As of now, Aadi Bioscience's Gross Profit is increasing as compared to previous years. The Aadi Bioscience's current Cost Of Revenue is estimated to increase to about 2.9 M, while Operating Income is forecasted to increase to (68.3 M).

	2021	2022	2023	2024 (projected)
Reconciled Depreciation	105K	159K	171K	122.1K
Interest Income	13K	2.4M	6.5M	6.8M

Reconciled Depreciation Interest Income

Aadi Bioscience income statement Correlations

	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Net Income	Interest Expense	Selling General Administrative	Gross Profit	Cost Of Revenue	Total Other Income Expense Net	Depreciation And Amortization	Research Development	Income Tax Expense	Total Revenue	Net Income From Continuing Ops	Non Operating Income Net Other	Selling And Marketing Expenses	Non Recurring	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Other Operating Expenses		-0.78	-0.78	-0.98	1.0	-0.76	-0.76	0.3	0.99	0.76	0.94	0.74	0.1	0.87	-0.87	-0.14	-0.72	0.62	-0.78	0.83	-0.56	0.92	0.91	0.91
Operating Income	-0.78		1.0	0.84	-0.79	1.0	1.0	-0.38	-0.78	-0.4	-0.64	-0.54	-0.68	-0.68	0.6	0.5	0.98	-0.6	0.48	-0.79	0.34	-0.6	-0.58	-0.85
Ebit	-0.78	1.0		0.84	-0.78	1.0	1.0	-0.38	-0.78	-0.39	-0.64	-0.54	-0.68	-0.67	0.6	0.5	0.98	-0.6	0.48	-0.79	0.34	-0.6	-0.58	-0.85
Ebitda	-0.98	0.84	0.84		-0.98	0.83	0.82	-0.2	-0.97	-0.67	-0.91	-0.7	-0.18	-0.87	0.88	0.21	0.79	-0.59	0.73	-0.81	0.52	-0.89	-0.87	-0.93
Total Operating Expenses	1.0	-0.79	-0.78	-0.98		-0.76	-0.76	0.31	0.99	0.76	0.93	0.73	0.11	0.87	-0.87	-0.14	-0.72	0.63	-0.77	0.83	-0.55	0.91	0.9	0.91
Income Before Tax	-0.76	1.0	1.0	0.83	-0.76		1.0	-0.39	-0.76	-0.37	-0.61	-0.49	-0.7	-0.65	0.58	0.52	0.98	-0.6	0.44	-0.78	0.29	-0.56	-0.55	-0.84
Net Income	-0.76	1.0	1.0	0.82	-0.76	1.0		-0.39	-0.76	-0.37	-0.61	-0.5	-0.71	-0.65	0.57	0.53	0.98	-0.6	0.45	-0.78	0.31	-0.56	-0.55	-0.84
Interest Expense	0.3	-0.38	-0.38	-0.2	0.31	-0.39	-0.39		0.26	0.48	0.09	0.08	0.43	0.23	0.04	-0.3	-0.33	0.64	-0.03	0.52	-0.02	0.04	0.03	0.21
Selling General Administrative	0.99	-0.78	-0.78	-0.97	0.99	-0.76	-0.76	0.26		0.73	0.93	0.72	0.12	0.88	-0.9	-0.06	-0.74	0.58	-0.75	0.82	-0.5	0.91	0.9	0.94
Gross Profit	0.76	-0.4	-0.39	-0.67	0.76	-0.37	-0.37	0.48	0.73		0.67	0.55	-0.19	0.61	-0.54	0.17	-0.26	0.48	-0.58	0.56	-0.45	0.65	0.65	0.51
Cost Of Revenue	0.94	-0.64	-0.64	-0.91	0.93	-0.61	-0.61	0.09	0.93	0.67		0.86	-0.06	0.85	-0.9	0.06	-0.6	0.54	-0.9	0.77	-0.73	1.0	1.0	0.85
Total Other Income Expense Net	0.74	-0.54	-0.54	-0.7	0.73	-0.49	-0.5	0.08	0.72	0.55	0.86		0.04	0.65	-0.58	0.13	-0.5	0.3	-0.92	0.55	-0.95	0.87	0.89	0.6
Depreciation And Amortization	0.1	-0.68	-0.68	-0.18	0.11	-0.7	-0.71	0.43	0.12	-0.19	-0.06	0.04		0.06	0.1	-0.62	-0.73	0.31	0.1	0.35	0.08	-0.1	-0.12	0.29
Research Development	0.87	-0.68	-0.67	-0.87	0.87	-0.65	-0.65	0.23	0.88	0.61	0.85	0.65	0.06		-0.84	0.09	-0.63	0.62	-0.55	0.75	-0.49	0.83	0.82	0.91
Income Tax Expense	-0.87	0.6	0.6	0.88	-0.87	0.58	0.57	0.04	-0.9	-0.54	-0.9	-0.58	0.1	-0.84		-0.06	0.58	-0.55	0.68	-0.75	0.39	-0.89	-0.88	-0.9
Total Revenue	-0.14	0.5	0.5	0.21	-0.14	0.52	0.53	-0.3	-0.06	0.17	0.06	0.13	-0.62	0.09	-0.06		0.51	-0.31	-0.03	-0.28	-0.15	0.11	0.12	-0.14
Net Income From Continuing Ops	-0.72	0.98	0.98	0.79	-0.72	0.98	0.98	-0.33	-0.74	-0.26	-0.6	-0.5	-0.73	-0.63	0.58	0.51		-0.57	0.45	-0.77	0.29	-0.56	-0.54	-0.84
Non Operating Income Net Other	0.62	-0.6	-0.6	-0.59	0.63	-0.6	-0.6	0.64	0.58	0.48	0.54	0.3	0.31	0.62	-0.55	-0.31	-0.57		-0.35	0.92	-0.24	0.5	0.48	0.65
Selling And Marketing Expenses	-0.78	0.48	0.48	0.73	-0.77	0.44	0.45	-0.03	-0.75	-0.58	-0.9	-0.92	0.1	-0.55	0.68	-0.03	0.45	-0.35		-0.61	0.85	-0.91	-0.92	-0.59
Non Recurring	0.83	-0.79	-0.79	-0.81	0.83	-0.78	-0.78	0.52	0.82	0.56	0.77	0.55	0.35	0.75	-0.75	-0.28	-0.77	0.92	-0.61		-0.41	0.73	0.72	0.85
Tax Provision	-0.56	0.34	0.34	0.52	-0.55	0.29	0.31	-0.02	-0.5	-0.45	-0.73	-0.95	0.08	-0.49	0.39	-0.15	0.29	-0.24	0.85	-0.41		-0.75	-0.77	-0.38
Net Interest Income	0.92	-0.6	-0.6	-0.89	0.91	-0.56	-0.56	0.04	0.91	0.65	1.0	0.87	-0.1	0.83	-0.89	0.11	-0.56	0.5	-0.91	0.73	-0.75		1.0	0.83
Interest Income	0.91	-0.58	-0.58	-0.87	0.9	-0.55	-0.55	0.03	0.9	0.65	1.0	0.89	-0.12	0.82	-0.88	0.12	-0.54	0.48	-0.92	0.72	-0.77	1.0		0.81
Reconciled Depreciation	0.91	-0.85	-0.85	-0.93	0.91	-0.84	-0.84	0.21	0.94	0.51	0.85	0.6	0.29	0.91	-0.9	-0.14	-0.84	0.65	-0.59	0.85	-0.38	0.83	0.81

Click cells to compare fundamentals

Aadi Bioscience Account Relationship Matchups

Aadi Bioscience income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Operating Expenses	22.6M	16.5M	38.1M	74.2M	96.3M	101.1M
Operating Income	(22.6M)	(2.5M)	(111.2M)	(59.0M)	(71.9M)	(68.3M)
Ebit	(22.6M)	(2.5M)	(111.2M)	(59.0M)	(71.9M)	(68.3M)
Ebitda	(22.5M)	(2.7M)	(35.5M)	(56.6M)	(71.8M)	(68.2M)
Total Operating Expenses	22.5M	16.5M	38.1M	72.8M	93.5M	98.2M
Income Before Tax	(23.3M)	(3.5M)	(110.1M)	(60.5M)	(65.8M)	(62.5M)
Net Income	(23.3M)	(3.5M)	(110.1M)	(57.0M)	(65.8M)	(62.5M)
Interest Expense	0.0	815K	665K	230K	231K	224.8K
Selling General Administrative	1.9M	2.1M	18.5M	40.2M	45.3M	47.6M
Gross Profit	672.5K	13.8M	724K	13.9M	21.5M	22.6M
Total Other Income Expense Net	(689.9K)	(927K)	1.1M	(1.6M)	6.2M	6.5M
Depreciation And Amortization	76.5K	(103K)	75.8M	2.4M	169K	160.6K
Research Development	12.8M	15.0M	19.7M	32.7M	48.9M	25.0M
Income Tax Expense	778.2K	1.3K	2K	(3.5M)	(3.2M)	(3.0M)
Total Revenue	749K	14M	1M	15.2M	24.4M	13.8M
Net Income From Continuing Ops	(23.3M)	(4.3M)	(110.1M)	(60.5M)	(63.4M)	(66.6M)
Net Income Applicable To Common Shares	(13.2M)	(4.3M)	(110.1M)	(60.5M)	(54.5M)	(57.2M)

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aadi Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aadi Bioscience's short interest history, or implied volatility extrapolated from Aadi Bioscience options trading.

Pair Trading with Aadi Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aadi Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aadi Bioscience will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aadi Stock

0.69

EOLS

Evolus Inc Financial Report 14th of May 2024

Pair Corr

Moving against Aadi Stock

0.63

LPTX

Leap Therapeutics Financial Report 20th of May 2024

Pair Corr

The ability to find closely correlated positions to Aadi Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aadi Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aadi Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aadi Bioscience to buy it.

The correlation of Aadi Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aadi Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aadi Bioscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aadi Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:

How To Invest In Aadi

Details

Is Aadi Stock a good investment?

Details

What is Aadi Bioscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.

	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.44)

Revenue Per Share

0.905

Quarterly Revenue Growth

0.21

Return On Assets

(0.28)

Return On Equity

(0.50)

The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aadi Historical Income Statement

About Aadi Income Statement Analysis

Aadi Bioscience Income Statement Chart

Other Operating Expenses

Cost Of Revenue

Aadi Bioscience income statement Correlations

Aadi Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aadi Bioscience income statement Accounts

Pair Trading with Aadi Bioscience

Moving together with Aadi Stock

Moving against Aadi Stock

Complementary Tools for Aadi Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Ebit

Total Operating Expenses	- 0.98	Ebitda
Ebitda	- 0.98	Other Operating Expenses
Selling General Administrative	- 0.97	Ebitda
Tax Provision	- 0.95	Total Other Income Expense Net
Reconciled Depreciation	- 0.93	Ebitda
Interest Income	- 0.92	Selling And Marketing Expenses